Profil
Dr. Horacio Plotkin, MD, is Chief Medical Officer at Retrophin, Inc.
He received his doctorate degree from Universidad de Buenos Aires.
Anciens postes connus de Horacio Plotkin
| Sociétés | Poste | Fin |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2020 |
| TRAVERE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2016 |
Formation de Horacio Plotkin
| Universidad de Buenos Aires | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
